Glenmark Pharmaceuticals informs about media release

21 Sep 2021 Evaluate

Glenmark Pharmaceuticals has informed that it attached media release on 21st September 2021 titled ‘Glenmark Pharmaceuticals receives ANDA approval for Clindamycin Phosphate Foam, 1%’.

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

1046.00 11.80 (1.14%)
24-Apr-2024 10:20 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1496.55
Dr. Reddys Lab 5970.00
Cipla 1375.90
Zydus Lifesciences 918.15
Lupin 1560.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.